menu
    • menu

    Company profile for Saptalis pharm

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Saptalis Pharmaceuticals LLC was founded in 2015 with a goal to build a successful pharmaceutical company focused on the development, manufacturing and commercialization of specialty generic prescription (Rx) and Over-The- Counter (OTC) products. Saptalis operates at a 10,000 sq. ft. R&D facility with highly qualified and experienced team of pharmaceutical formulation scientists, analytical chemists and compliance specialists...
    Saptalis Pharmaceuticals LLC was founded in 2015 with a goal to build a successful pharmaceutical company focused on the development, manufacturing and commercialization of specialty generic prescription (Rx) and Over-The- Counter (OTC) products. Saptalis operates at a 10,000 sq. ft. R&D facility with highly qualified and experienced team of pharmaceutical formulation scientists, analytical chemists and compliance specialists in regulatory affairs and pharmaceutical product manufacturing. The facility is fully equipped with state of the art equipment used in pharmaceutical product development and analytical method development

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Saptalis pharmUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    45 Davids Dr Hauppauge, NY 11788
    Telephone
    Telephone
    +(631) 231-2751
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.saptalis.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/saptalis-pharmaceutcals-llc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution
    Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution

    18 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250618093628/en/Saptalis-Pharmaceuticals-Launches-Fluoxetine-Oral-Solution-USP-20-mg5-mL

    BUSINESSWIRE
    18 Jun 2025
    Share Share
    Saptalis Pharmaceuticals Launches Likmez® Oral Suspension
    Saptalis Pharmaceuticals Launches Likmez® Oral Suspension

    20 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250520874040/en/Saptalis-Pharmaceuticals-Announces-the-Launch-of-LIKMEZ-The-First-and-Only-US-FDA-Approved-Ready-to-Use-Oral-Suspension-of-Metronidazole

    BUSINESSWIRE
    20 May 2025
    Share Share
    Saptalis`s Generics Glycopyrrolate Receives Approval in US
    Saptalis`s Generics Glycopyrrolate Receives Approval in US

    07 Oct 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216297

    FDA
    07 Oct 2024
    Share Share
    Saptalis pharm`s Generic Cyclosporine Receives Approval in U.S
    Saptalis pharm`s Generic Cyclosporine Receives Approval in U.S

    05 Jul 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211943

    FDA
    05 Jul 2024
    Share Share
    Saptalis pharm`s Generic Lithium Citrate Receives Approval in the U.S.
    Saptalis pharm`s Generic Lithium Citrate Receives Approval in the U.S.

    18 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217183

    FDA
    18 Mar 2024
    Share Share
    Appili Tx Expands ATI-1501 Commercial Agreement with Saptalis Pharmaceuticals
    Appili Tx Expands ATI-1501 Commercial Agreement with Saptalis Pharmaceuticals

    08 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220208005344/en

    BUSINESSWIRE
    08 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search